Phibro Animal Health (PAHC) Return on Capital Employed (2014 - 2026)

Phibro Animal Health's Return on Capital Employed history runs 13 years deep, the most recent figure standing at 15.74% for Q1 2026.

• On a quarterly basis, Return on Capital Employed rose 654.0% year-over-year to 15.74% in Q1 2026; TTM through Mar 2026 was 15.74%, a 654.0% increase from a year earlier, with the FY2025 full-year figure at 12.58%, up 568.0% from the prior year.
• Return on Capital Employed rose to 15.74% in Q1 2026 per PAHC's latest filing, from 15.17% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 15.74% in Q1 2026 and bottomed at 6.87% in Q2 2024.
• The 5-year median for Return on Capital Employed is 9.14% (2024), against an average of 9.97%.
• Across the five-year window, Return on Capital Employed sank 295 bps in 2023 and soared 654 bps in 2026, its largest moves.
• Year by year, Return on Capital Employed stood at 9.09% in 2022, then declined by 19 bps to 7.34% in 2023, then increased by 25 bps to 9.14% in 2024, then soared by 66 bps to 15.17% in 2025, then climbed by 4 bps to 15.74% in 2026.
• Per Business Quant, the three latest PAHC Return on Capital Employed figures stand at 15.74% (Q1 2026), 15.17% (Q4 2025), and 13.06% (Q3 2025).